Cargando…

Immunotherapy and the belly of the beast

Detalles Bibliográficos
Autores principales:	Merghoub, Taha, Wolchok, Jedd D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Rockefeller University Press 2014
Materias:	News
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4235645/ https://www.ncbi.nlm.nih.gov/pubmed/25403805 http://dx.doi.org/10.1084/jem.21112insight3

Ejemplares similares

Myeloid-derived suppressor cells and the efficacy of CD8(+) T-cell immunotherapy
por: Lesokhin, Alexander M., et al.
Publicado: (2013)

Direct comparisons of T cell costimulation and checkpoint blockade in the setting of tumor-targeted monoclonal antibody therapy
por: Khalil, Danny, et al.
Publicado: (2015)

Targeting myeloid-derived suppressor cells with colony stimulating factor-1 receptor blockade can reverse immune resistance to immunotherapy in indoleamine 2,3-dioxygenase-expressing tumors
por: Holmgaard, Rikke B., et al.
Publicado: (2016)

Refusing to TAP out: 16 new human TEIPPs identified
por: Gigoux, Mathieu, et al.
Publicado: (2018)

Shared cancer neoantigens: Making private matters public
por: Klebanoff, Christopher A., et al.
Publicado: (2018)

Taming the beast within: resveratrol suppresses colitis and prevents colon cancer
por: Hofseth, Lorne J., et al.
Publicado: (2010)

Beastly Beauty Products: Exposure to Inorganic Mercury in Skin-Lightening Creams
por: Washam, Cynthia
Publicado: (2011)

Career beasts and how to cope with them: From toxic workplace culture to healthy competition
por: Vlăduț, Cătălina, et al.
Publicado: (2022)

Expression of indoleamine 2.3-dioxygenase by tumors induces local and systemic immunosuppressive effects in a murine melanoma model
por: Holmgaard, Rikke B, et al.
Publicado: (2014)

Potentiation of immunomodulatory antibodies with oncolytic viruses for therapy of poorly-immunogenic tumors
por: Zamarin, Dmitriy, et al.
Publicado: (2014)

Blockade of Treg derived TGF-β abrogates suppression of effector T cell function within the tumor microenvironment
por: Budhu, Sadna, et al.
Publicado: (2013)

Impairment of Treg suppression by GITR ligation is effective selectively in the context of a pro-inflammatory tumor microenvironment
por: Zappasodi, Roberta, et al.
Publicado: (2014)

Blockade of surface bound TGF-β abrogates Treg suppression of effector T cell function within the tumor microenvironment
por: Budhu, Sadna, et al.
Publicado: (2014)

Heat-inactivated modified vaccinia virus Ankara boosts Th1 cellular and humoral immunity as a vaccine adjuvant
por: Yang, Ning, et al.
Publicado: (2022)

Tumor antigens for cancer immunotherapy: therapeutic potential of xenogeneic DNA vaccines
por: Srinivasan, Roopa, et al.
Publicado: (2004)

Investigations from the Belly of the Beast: N-Terminally Labeled Incretin Peptides That Are Both Potent Receptor Agonists and Stable to Protease Digestion
por: Berger, Allison Ann, et al.
Publicado: (2021)

Domesticating the beast
por: Walbot, Virginia
Publicado: (2013)

The Tail of the Beast
Publicado: (1882)

The Beauty and the Beast
por: Bernard, Christophe
Publicado: (2021)

Awakening the beast
Publicado: (2009)

Localized oncolytic virotherapy inflames distant tumors and synergizes with immune checkpoint blockade leading to systemic tumor rejection
por: Zamarin, Dmitriy, et al.
Publicado: (2013)

Pre-existing Immunity to Oncolytic Virus Potentiates Its Immunotherapeutic Efficacy
por: Ricca, Jacob M., et al.
Publicado: (2018)

The delicate balance of melanoma immunotherapy
por: Gyorki, David E, et al.
Publicado: (2013)

Melanoma: From Incurable Beast to a Curable Bet. The Success of Immunotherapy
por: Ascierto, Maria Libera, et al.
Publicado: (2015)

Taming the BEAST—A Community Teaching Material Resource for BEAST 2
por: Barido-Sottani, Joëlle, et al.
Publicado: (2018)

The future of cancer immunotherapy: microenvironment-targeting combinations
por: Murciano-Goroff, Yonina R., et al.
Publicado: (2020)

Targeting tumor-necrosis factor receptor pathways for tumor immunotherapy
por: Schaer, David A, et al.
Publicado: (2014)

Fabulous beasts and demons
Publicado: (1977)

Beauty versus the beast
por: Caldwell, Clare Elizabeth
Publicado: (2013)

I slew the beast!
por: Mansfield, James B.
Publicado: (2016)

Wild Beasts and Snakes
Publicado: (1897)

Taming the beasts inside
por: Ryu, Erica P, et al.
Publicado: (2021)

Elucidating mechanisms of antitumor immunity mediated by live oncolytic vaccinia and heat-inactivated vaccinia
por: Wang, Weiyi, et al.
Publicado: (2021)

Man and beast : comparative social behavior /
Publicado: (1971)

Fire in the Belly? Sulfur-Reducing Gut Microbes Fuel Arsenic Thiolation
por: Potera, Carol
Publicado: (2014)

Beast or angel? : choices that make us human
por: Dubos, René J. (René Jules), 1901-1982

Intratumoral modulation of the inducible co-stimulator ICOS by recombinant oncolytic virus promotes systemic anti-tumour immunity
por: Zamarin, Dmitriy, et al.
Publicado: (2017)

An MHC-restricted antibody-based chimeric antigen receptor requires TCR-like affinity to maintain antigen specificity
por: Maus, Marcela V, et al.
Publicado: (2017)

Alphavirus Replicon Particles Expressing TRP-2 Provide Potent Therapeutic Effect on Melanoma through Activation of Humoral and Cellular Immunity
por: Avogadri, Francesca, et al.
Publicado: (2010)

Opportunistic infections in patients treated with immunotherapy for cancer
por: Kyi, Chrisann, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_rh4udaf96vomc6c46uc0fl2rnt